nach oben

Erschienen in:

01.03.2013 | Research Article

Retrospective study assessing the role of MRI in the diagnostic procedures for early breast carcinoma: a correlation of new foci in the MRI with tumor pathological features

verfasst von: I. Calvo-Plaza, L. Ugidos, C. Miró, P. Quevedo, M. Parras, C. Márquez, J. J. de la Cruz, A. Suárez-Gauthier, F. J. Pérez, M. Herrero, M. Marcos, M. García-Aranda, M. Hidalgo, L. G. Estévez

Erschienen in: Clinical and Translational Oncology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Use of breast magnetic resonance imaging (MRI) to detect breast cancer has generated significant debate. We analyze the role of breast MRI in the detection of additional disease and the need to perform additional biopsies in early breast carcinoma patients. In addition, we correlate the detection of new foci with tumor pathological features.

Methods

Early breast carcinoma patients that had undergone an MRI as well as a mammography as diagnostic procedures were included in the study. The following pathologic features were studied: carcinoma type, histological grade, estrogen receptors (ER), progesterone receptors (PR), HER2 and Ki67. Univariate analysis was conducted to ascertain significant correlation among detection of new foci and each of the tumor pathological features.

Results

Data from 98 patients have been analyzed: median age 49 years (range 35–79); carcinoma type: (a) infiltrative ductal carcinoma (n = 73, 74 %), (b) infiltrative lobular cancer (n = 12, 12 %), (c) ductal carcinoma in situ (n = 6, 6 %); amplified HER2 (n = 18, 18 %); grade III (n = 33, 33 %); Ki67 ≥ 25 % (n = 33, 33.67 %); positive ER and PR (n = 79, 80 %); triple negative tumors (n = 8, 8 %). MRI detected additional disease in 38 cases (39.58 %), and 20 led to an additional biopsy (20.4 %). Thirty-eight patients (39 %) underwent mastectomy. We found a statistically significant correlation between new foci in MRI and high Ki67 ≥ 25 % (p < 0.005). No other statistically significant correlation was established.

Conclusion

MRI detected additional disease in 39 % cases, requiring an additional biopsy 20 %. Tumors with high proliferative index were significantly correlated with the detection of new foci in MRI.

Jemal A et al (2010) Cancer statistics. CA Cancer J Clin 60:277–300PubMedCrossRef

Gralow J et al (2008) Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening—a report from the American Society of Clinical Oncology. J Clin Oncol 26(2):313–325PubMedCrossRef

Fisher B et al (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347(16):1233–1241PubMedCrossRef

Poggi MM et al (2003) Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 98(4):697–702PubMedCrossRef

Nakamura S et al (2002) Breast-conserving therapy for ductal carcinoma in situ: a 20-year experience with excision plus radiation therapy. Am J Surg 184(5):403–409PubMedCrossRef

Arriagada R et al (1996) Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 14(5):1558–1564PubMed

Veronesi U et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232PubMedCrossRef

Jatoi I, Proschan MA (2005) Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol 28(3):289–294PubMedCrossRef

Ganz PA et al (2004) Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J Natl Cancer Inst 96(5):376–387PubMedCrossRef

10.

Blair S et al (2006) The efficacy of breast MRI in predicting breast conservation therapy. J Surg Oncol 94(3):220–225PubMedCrossRef

11.

Schnall MD et al (2005) MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 92(1):32–38PubMedCrossRef

12.

Rieber A et al (2002) Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 12(7):1711–1719PubMedCrossRef

13.

Thibault F et al (2004) MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy. AJR Am J Roentgenol 183(4):1159–1168PubMed

14.

Weatherall PT et al (2001) MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with X-ray mammography and palpation. J Magn Reson Imaging 13(6):868–875PubMedCrossRef

15.

Partridge SC et al (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179(5):1193–1199PubMed

16.

Harms SE et al (1993) MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187(2):493–501PubMed

17.

Houssami N et al (2008) Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26(19):3248–3258PubMedCrossRef

18.

Nguyen PL et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26(14):2373–2378PubMedCrossRef

19.

Katipamula R et al (2009) Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27(25):4082–4088PubMedCrossRef

20.

McGuire KP et al (2009) Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 16(10):2682–2690PubMedCrossRef

21.

Bleicher RJ et al (2009) Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 209(2):180–7 (quiz 294–295)

22.

Pengel KE et al (2009) The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat 116(1):161–169PubMedCrossRef

23.

Turnbull LW et al (2010) Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer scheduled for wide local excision (COMICE). Health Technol Assess. 14(1):1–182

24.

Morrow M, Harris JR (2009) More mastectomies: is this what patients really want? J Clin Oncol 27(25):4038–4040PubMedCrossRef

25.

Solin LJ et al (2008) Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 26(3):386–391PubMedCrossRef

26.

Morris EA (2006) Breast MR imaging lexicon updated. Magn Reson Imaging Clin N Am 14(3):293–303PubMedCrossRef

27.

Morrow M, Freedman G (2006) A clinical oncology perspective on the use of breast MR. Magn Reson Imaging Clin N Am 14(3):363–378, vi

28.

Wapnir IL et al (2006) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 24(13):2028–2037PubMedCrossRef

29.

Sardanelli F (2010) Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes. Breast 19(1):3–6PubMedCrossRef

30.

Zhang Y et al (2002) The role of contrast-enhanced MR mammography for determining candidates for breast conservation surgery. Breast Cancer 9(3):231–239PubMedCrossRef

31.

Furman B et al (2003) Effect of 0.5 Tesla magnetic resonance imaging on the surgical management of breast cancer patients. Am J Surg 186(4):344–347PubMedCrossRef

32.

Lehman CD et al (2007) MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356(13):1295–1303PubMedCrossRef

33.

Ikeda DM, Baker DR, Daniel BL (2000) Magnetic resonance imaging of breast cancer: clinical indications and breast MRI reporting system. J Magn Reson Imaging 12(6):975–983PubMedCrossRef

34.

Kaufmann M et al (2010) Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer 116(5):1184–1191PubMedCrossRef

35.

Houssami N, Hayes DF (2009) Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin 59(5):290–302PubMedCrossRef

36.

Turnbull L et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375(9714):563–571PubMedCrossRef

37.

Morrow M (2005) Limiting breast surgery to the proper minimum. Breast 14(6):523–526PubMedCrossRef

38.

Marklund M et al (2008) Contrast kinetics of the malignant breast tumour–border versus centre enhancement on dynamic midfield MRI. Eur J Radiol 65(2):279–285PubMedCrossRef

39.

Sorbero ME et al (2009) Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 16(6):1597–1605PubMedCrossRef

40.

Tuttle TM et al (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25(33):5203–5209PubMedCrossRef

41.

Tuttle TM (2009) Magnetic resonance imaging and contralateral prophylactic mastectomy: the “no mass” effect? Ann Surg Oncol 16(6):1461–1462PubMedCrossRef

42.

Kneeshaw PJ et al (2003) Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur J Surg Oncol 29(1):32–37PubMedCrossRef

43.

Mann RM et al (2010) The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 119(2):415–422PubMedCrossRef

44.

Mann RM et al (2008) MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 107(1):1–14PubMedCrossRef

45.

Kuhl CK, Schild HH (2000) Dynamic image interpretation of MRI of the breast. J Magn Reson Imaging 12(6):965–974PubMedCrossRef

46.

Nagashima T et al (2002) Dynamic-enhanced MRI predicts metastatic potential of invasive ductal breast cancer. Breast Cancer 9(3):226–230PubMedCrossRef

47.

Nagashima T et al (2006) Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients. Eur J Radiol 60(2):270–274PubMedCrossRef

Titel: Retrospective study assessing the role of MRI in the diagnostic procedures for early breast carcinoma: a correlation of new foci in the MRI with tumor pathological features
verfasst von: I. Calvo-Plaza
L. Ugidos
C. Miró
P. Quevedo
M. Parras
C. Márquez
J. J. de la Cruz
A. Suárez-Gauthier
F. J. Pérez
M. Herrero
M. Marcos
M. García-Aranda
M. Hidalgo
L. G. Estévez
Publikationsdatum: 01.03.2013
Verlag: Springer Milan
Erschienen in: Clinical and Translational Oncology / Ausgabe 3/2013
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-012-0899-7

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Retrospective study assessing the role of MRI in the diagnostic procedures for early breast carcinoma: a correlation of new foci in the MRI with tumor pathological features

Abstract

Background

Methods

Results

Conclusion

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

A high body mass index is not a worse prognostic factor for endometrial carcinoma in a predominantly obese population

IMRT: preliminary results in a series of advanced head-and-neck cancer patients

Multidisciplinary management of locally advanced–borderline resectable adenocarcinoma of the head of the pancreas

Viruses in cancer treatment

Practice patterns in the management of prostate cancer in Spain: results from a national survey among radiation oncologists in 2009

Identification of valid reference housekeeping genes for gene expression analysis in tumor neovascularization studies

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie